AKT1 and lip and oral cavity carcinoma: As well, its anticancer activity toward mitochondria-targeted antioxidants (GSH) is closely associated with inhibition of ROS-sensitive AKT/ERK survival signaling pathways and glycolysis in human oral cancer cells.